BioCentury
ARTICLE | Company News

RecepterBio Inc., Telik deal

August 25, 2008 7:00 AM UTC

ReceptorBio received exclusive rights from Telik to develop and commercialize Telik’s small molecule insulin receptor activators in the U.S., Europe and other undisclosed countries. The undisclosed mo...